John A Rathmacher
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 22, 2017 | NIH | SBIR Phase II 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | $151K | METABOLIC TECHNOLOGIES, INC. |
| Jul 5, 2017 | NIH | SBIR Phase II Nutritional Intervention for Age-Related Muscular Function and Strength Losses | $98K | METABOLIC TECHNOLOGIES, INC. |
| Jun 21, 2017 | NIH | SBIR Phase II 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | $78K | METABOLIC TECHNOLOGIES, INC. |
| Sep 22, 2016 | NIH | SBIR Phase II 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | $672K | METABOLIC TECHNOLOGIES, INC. |
| Feb 29, 2016 | NIH | SBIR Phase II Nutritional Intervention for Age-Related Muscular Function and Strength Losses | $375K | METABOLIC TECHNOLOGIES, INC. |
Peer ranks
Federal funding#84
Awards as PI#19
Patents#14
Companies
- METABOLIC TECHNOLOGIES, INC.Linked by awards
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.